BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Anixa Biosciences Inc.

Headquarters: San Jose, CA, United States
Year Founded: 1982
Status: Public
Industry Sector: HealthTechnology
CEO: Amit D. Kumar, PhD, MBA
Number Of Employees: 5
Enterprise Value: $90,841,000
PE Ratio: -7.17
Exchange/Ticker 1: NASDAQ:ANIX
Exchange/Ticker 2: N/A
Latest Market Cap: $89,829,400

BioCentury | Oct 8, 2024
Management Tracks

Veteran investor Oleg Nodelman joins Galapagos board

Plus: New CEOs at QuantX, Oak Hill, and updates from Every Cure, Mosaic, Anixa and more 
BioCentury | Dec 22, 2023
Distillery Therapeutics

Bispecific SIGLEC7xFSHR NK cell engager for ovarian cancer

BioCentury | Sep 11, 2021
Management Tracks

New CEO for Eden following conviction of JHL execs

Plus: Mavilio, Loggia join Orchard and updates from PMV, Verseau, Apexigen, VectivBio, Protagonist and more
Items per page:
1 - 4 of 4